Published in J Natl Cancer Inst on November 01, 1973
Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. J Exp Med (1974) 5.73
Vaccines and cell-mediated immunity. Bacteriol Rev (1974) 5.42
Influence of dose and route of antigen injection on the immunological induction of T cells. J Exp Med (1974) 4.99
Feedback inhibition of specifically sensitized lymphocytes. J Exp Med (1974) 3.11
Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. J Clin Invest (1990) 2.91
The modifying effect of BCG on the immunological induction of T cells. J Exp Med (1974) 2.30
Suppressor T-cells in BCG-infected mice. Infect Immun (1979) 1.88
Comparative studies with various substrains of Mycobacterium bovis BCG on the production of an antigenic protein, MPB70. Infect Immun (1983) 1.83
A stable form of delayed-type hypersensitivity. J Exp Med (1975) 1.68
Strain difference of delayed-type hypersensitivity to BCG and its genetic control in mice. Infect Immun (1978) 1.59
The specificity of suppressor T cells induced by chronic Mycobacterium avium infection in mice. Clin Exp Immunol (1981) 1.42
Opposite effects of BCG on spleen and lymph node cells: lymphocyte proliferation and immunoglobulin synthesis. Infect Immun (1978) 1.29
Epicutaneous induction of hyporeactivity in contact sensitization. Demonstration of suppressor cells induced by contact with 2,4-dinitrothiocyanatebenzene. Immunology (1975) 1.25
Local immune response to Mycobacterium lepraemurium in C3H and C57Bl/6 mice. Clin Exp Immunol (1979) 1.24
Bacille Calmette-Guérin infection in the mouse. Regulation of macrophage plasminogen activator by T lymphocytes and specific antigen. J Exp Med (1978) 1.22
Control of the Bcg gene of early resistance in mice to infections with BCG substrains and atypical mycobacteria. Clin Exp Immunol (1986) 1.19
Suppressed or enhanced antibody responses in vitro after BCG treatment of mice: importance of BCG viability. Immunology (1979) 1.14
Host defenses in murine malaria: nonspecific resistance to Plasmodium berghei generated in response to Mycobacterium bovis infection or Corynebacterium parvum stimulation. Infect Immun (1981) 1.07
Systemic bacillus Calmette-Guérin (BCG) activates natural suppressor cells. Proc Natl Acad Sci U S A (1978) 1.06
Oral BCG vaccine in Crohn's disease. Gut (1979) 1.00
Cellular changes in the lymphoreticular tissues of C57L/J mice infected with Echinococcus multilocularis cysts. Immunology (1978) 0.99
Immunological behavior after mycobacterial infection in selected lines of mice with high or low antibody responses. Infect Immun (1979) 0.98
Delayed-type hypersensitivity to rabies virus in mice: assay of active or passive sensitization by the footpad test. Infect Immun (1978) 0.98
Restoration of cell-mediated immunity to animals blocked by a humoral response. J Exp Med (1974) 0.96
Adjuvant and mitogenic properties of a supernatant fraction of sonically treated Myobacterium bovis (BCG). Infect Immun (1976) 0.94
Mycobacterium bovis, BCG, modulation of murine antibody responses: influence of dose and degree of aggregation of live or dead organisms. Br J Exp Pathol (1982) 0.89
Host defenses in murine malaria: evaluation of the mechanisms of immunity to Plasmodium yoelii infection. Infect Immun (1979) 0.87
Stimulation of lymphocyte proliferation by killed mycobacteria and other bacterial species. Infect Immun (1976) 0.87
Nonspecific stimulation of lymphocytes by tuberculin. Infect Immun (1977) 0.87
Non-specific immunotherapy with bacille Calmette-Guérin (BCG). Clin Exp Immunol (2001) 0.84
Analysis of the cell wall of five strains of Myocbacterium tuberculosis BCG and of an attenuated human strain, W 115. Infect Immun (1976) 0.83
Effect of systemic BCG infection in syrian golden hamsters. Infect Immun (1976) 0.80
Resistance of high and low antibody responder lines of mice to the growth of avirulent (BCG) and virulent (H37Rv) strains of mycobacteria. Clin Exp Immunol (1985) 0.77
Kinetics of different specific immunological parameters after rabies vaccination in mice. Infect Immun (1979) 0.76
Canine migration inhibitory factor: effect of Corynebacterium parvum administration. Infect Immun (1977) 0.75
Relationship between the tuberculin-type and Jones-Mote-type hypersensitivities: suppression of basophil infiltration by mycobacterial adjuvant. Immunology (1986) 0.75
High-viability lyophilized Bacille Calmette-Guérin vaccine produced by deep-culture technique. Appl Environ Microbiol (1977) 0.75
Immunotherapy of guinea pig line 10 hepatoma with nonliving BCG cells in aqueous medium. Infect Immun (1979) 0.75
Ineffectiveness and toxicity of BCG vaccine for the prevention of recurrent genital herpes. Antimicrob Agents Chemother (1985) 0.75
Immunosuppressive activity of BCG: effects of adjuvant disease, lymphocyte subpopulations, and homing of thoracic duct cells in rats. Infect Immun (1979) 0.75
Host defenses in murine malaria: failure of vaccination with formolized blood parasites to protect athymic mice from Plasmodium berghei. Infect Immun (1980) 0.75
The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J Exp Med (1969) 20.62
Mechanisms of acquired resistance in mouse typhoid. J Exp Med (1966) 9.20
The host response to Calmette-Guérin bacillus infection in mice. J Exp Med (1969) 7.74
Cellular immunity. Prog Allergy (1967) 7.18
Host-parasite relations in mouse typhoid. J Exp Med (1966) 5.73
Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. J Exp Med (1974) 5.73
Delayed hypersensitivity and arthus reactivity in relation to host resistance in salmonella-infected mice. J Immunol (1968) 5.71
Influence of dose and route of antigen injection on the immunological induction of T cells. J Exp Med (1974) 4.99
Infection-immunity in experimental salmonellosis. J Exp Med (1966) 4.45
The immunology of antituberculous immunity. Am Rev Respir Dis (1968) 4.17
The mediator of cellular immunity. II. Migration of immunologically committed lymphocytes into inflammatory exudates. J Exp Med (1971) 4.13
The monocyte in cellular immunity. Semin Hematol (1970) 4.10
Immunopotentiation with BCG. II. Modulation of the response to sheep red blood cells. J Natl Cancer Inst (1973) 4.10
The relationship of delayed hypersensitivity to acquired cellular resistance. Br Med Bull (1967) 4.03
Resistance to intracellular infection. J Infect Dis (1971) 4.01
The mediator of cellular immunity. I. The life-span and circulation dynamics of the immunologically committed lymphocyte. J Exp Med (1971) 4.00
The relationship of delayed hypersensitivity to acquired antituberculous immunity. I. Tuberculin sensitivity and resistance to reinfection in BCG-vaccinated mice. Cell Immunol (1970) 3.94
The effect of anti-lymphocyte globulin on cell-mediated reistance to infection. J Exp Med (1969) 3.84
The histogenesis of immunologically committed lymphocytes. Cell Immunol (1972) 3.29
Salmonella enteritidis: AmpC plasmid-mediated inducible beta-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob Agents Chemother (1998) 3.17
Feedback inhibition of specifically sensitized lymphocytes. J Exp Med (1974) 3.11
A novel integron in Salmonella enterica serovar Enteritidis, carrying the bla(DHA-1) gene and its regulator gene ampR, originated from Morganella morganii. Antimicrob Agents Chemother (2000) 2.85
Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 beta-lactamase and which were isolated in 14 French hospitals. J Clin Microbiol (1994) 2.66
Molecular characterisation by PCR-restriction fragment length polymorphism of TEM beta-lactamases. FEMS Microbiol Lett (1995) 2.63
Outbreak of Klebsiella pneumoniae producing transferable AmpC-type beta-lactamase (ACC-1) originating from Hafnia alvei. FEMS Microbiol Lett (2000) 2.57
Cell-mediated resistance to aerogenic infection of the lung. Am Rev Respir Dis (1971) 2.48
Chromosomal beta-lactamase genes of Klebsiella oxytoca are divided into two main groups, blaOXY-1 and blaOXY-2. Antimicrob Agents Chemother (1996) 2.48
The effect of cytotoxic agents on the primary immune response to Listeria monocytogenes. J Exp Med (1969) 2.44
Evaluation of the automated phoenix system for potential routine use in the clinical microbiology laboratory. J Clin Microbiol (2004) 2.43
The modifying effect of BCG on the immunological induction of T cells. J Exp Med (1974) 2.30
An evaluation of the polymerase chain reaction amplicor Chlamydia trachomatis in male urine and female urogenital specimens. Sex Transm Dis (1994) 2.26
Characterisation of CMY-4, an AmpC-type plasmid-mediated beta-lactamase in a Tunisian clinical isolate of Proteus mirabilis. FEMS Microbiol Lett (1998) 2.09
Origin and impact of plasmid-mediated extended-spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis (1994) 1.94
Rapid diagnosis of extrapulmonary tuberculosis by PCR: impact of sample preparation and DNA extraction. J Clin Microbiol (2003) 1.91
Immune response to Mycobacterium tuberculosis in rats. Infect Immun (1973) 1.86
Characterization of FOX-3, an AmpC-type plasmid-mediated beta-lactamase from an Italian isolate of Klebsiella oxytoca. Antimicrob Agents Chemother (1998) 1.85
False-positive HIV antigens related to emergence of a 25-30 kD protein detected in organ recipients. AIDS (1992) 1.82
Susceptibility to leprosy is linked to the human NRAMP1 gene. J Infect Dis (1998) 1.79
Properties of lymphocytes which confer adoptive immunity to tuberculosis in rats. Immunology (1973) 1.79
The effect of cytotoxic agents on the passive transfer of cell-mediated immunity. J Exp Med (1969) 1.76
The relationship of delayed hypersensitivity to acquired antituberculous immunity. II. Effect of adjuvant on the allergenicity and immunogenicity of heat-killed tubercle bacilli. Cell Immunol (1970) 1.75
The J. Burns Amberson LECTURE The induction and expression of cell-mediated hypersensitivity in the lung. Am Rev Respir Dis (1971) 1.73
A stable form of delayed-type hypersensitivity. J Exp Med (1975) 1.68
Induction of cell-mediated immunity to Mycobacterium lepraemurium in susceptible mice. Infect Immun (1977) 1.67
An epidemic of tuberculosis with a high rate of tuberculin anergy among a population previously unexposed to tuberculosis, the Yanomami Indians of the Brazilian Amazon. Proc Natl Acad Sci U S A (1997) 1.55
Point mutation in the pribnow box, the molecular basis of beta-lactamase overproduction in Klebsiella oxytoca. Antimicrob Agents Chemother (1995) 1.53
The short lived small lymphocyte as a mediator of cellular immunity. Nature (1970) 1.51
A comparison of the Steenken minimal inhibitory concentration and the Canetti proportion methods for determining levels of drug resistance in cultures of Mycobacterium tuberculosis. Am Rev Respir Dis (1968) 1.48
beta-lactamase gene promoters of 71 clinical strains of Klebsiella oxytoca. Antimicrob Agents Chemother (1996) 1.47
Immunological control of macrophage proliferation in vivo. Infect Immun (1973) 1.46
Leprosy and BCG in southern Vietnam. Lancet (1990) 1.44
Deficit of interleukin 2 production associated with impaired T-cell proliferative responses in Mycobacterium lepraemurium infection. Infect Immun (1983) 1.42
The immunology of leprosy: speculations on the leprosy spectrum. Rev Infect Dis (1981) 1.38
Effects of bacterial lipopolysaccharide on the induction and expression of cell-mediated immunity. I. Depression of the afferent arc. J Immunol (1975) 1.37
Plasmid-mediated rifampin resistance encoded by an arr-2-like gene cassette in Klebsiella pneumoniae producing an ACC-1 class C beta-lactamase. Antimicrob Agents Chemother (2001) 1.31
Klebsiella oxytoca: resistance to aztreonam by overproduction of the chromosomally encoded beta-lactamase. FEMS Microbiol Lett (1994) 1.30
Granulomatous reaction to intradermal injection of lepromin (Mitsuda reaction) is linked to the human NRAMP1 gene in Vietnamese leprosy sibships. J Infect Dis (2000) 1.25
Local immune response to Mycobacterium lepraemurium in C3H and C57Bl/6 mice. Clin Exp Immunol (1979) 1.24
Systemic candidiasis in mice. II.--Main role of polymorphonuclear leukocytes in resistance to infection. Ann Immunol (Paris) (1980) 1.23
Viability, heat stability and immunogenicity of four BCG vaccines prepared from four different BCG strains. Ann Immunol (Paris) (1983) 1.23
Lactobacillus species identification, H2O2 production, and antibiotic resistance and correlation with human clinical status. J Clin Microbiol (1999) 1.22
The stability and immunogenicity of a dispersed-grown freeze-dried Pasteur BCG vaccine. J Biol Stand (1988) 1.12
Effects of bacterial lipopolysaccharide on the induction and expression of cell-mediated immunity. II. Stimulation of the efferent arc. J Immunol (1975) 1.11
Peritoneal exudate T lymphocytes with specificity to sheep red blood cells. I. Production and characterization as to function and phenotype. Immunology (1979) 1.10
Site of action of serum factors that block delayed-type hypersensitivity in mice. J Exp Med (1978) 1.07
Complex segregation analysis of leprosy in southern Vietnam. Genet Epidemiol (1995) 1.06
Cellular immunity. Ann Inst Pasteur (Paris) (1971) 1.06
Comparative in vitro activities of pristinamycin, its components, and other antimicrobial agents against anaerobic bacteria. Antimicrob Agents Chemother (1988) 1.04
Suppression of immunity to Mycobacterium lepraemurium infection. Infect Immun (1977) 1.04
IgG subclass distribution of antibody responses to protein and polysaccharide mycobacterial antigens in leprosy and tuberculosis patients. Clin Exp Immunol (1998) 1.03
The mediator of cellular immunity. V. Development of cellular resistance to infection in thymectomized irradiated rats. Cell Immunol (1973) 1.02
Detection of SHV-5 extended-spectrum beta-lactamase in Klebsiella pneumoniae strains isolated in Italy. Eur J Clin Microbiol Infect Dis (1996) 1.01
Cellular immunity and the parasite. Adv Exp Med Biol (1977) 1.01
Immunopotentiation with BCG. 3. Modulation of the response to a tumor-specific antigen. J Natl Cancer Inst (1973) 1.01
Antitumor activity of bacterial infection. I. Effect of Listeria monocytogenes on growth of a murine fibrosarcoma. J Natl Cancer Inst (1975) 0.99
Systemic candidiasis in mice. I.--Correlation between kidney infection and mortality rate. Ann Immunol (Paris) (1980) 0.99
Kinetics of circulating antibodies, immune complex and specific antibody-secreting cells in tuberculosis patients during 6 months of antimicrobial therapy. Tuber Lung Dis (2000) 0.99
Antitumor activity of bacterial infection. II. effect of Listeria monocytogenes on growth of a guinea pig hepatoma. J Natl Cancer Inst (1975) 0.99
Different time course patterns of local expression of delayed-type hypersensitivity to sheep red blood cells in mice. Cell Immunol (1992) 0.98
Delayed-type hypersensitivity to rabies virus in mice: assay of active or passive sensitization by the footpad test. Infect Immun (1978) 0.98
Immunological behavior after mycobacterial infection in selected lines of mice with high or low antibody responses. Infect Immun (1979) 0.98
Influence of dose and route of Mycobacterium lepraemurium inoculation on the production of interleukin 1 and interleukin 2 in C57BL/6 mice. Infect Immun (1984) 0.97
Restoration of cell-mediated immunity to animals blocked by a humoral response. J Exp Med (1974) 0.96
In-vitro susceptibility of Klebsiella oxytoca strains to 13 beta-lactams in the presence and absence of beta-lactamase inhibitors. J Antimicrob Chemother (1996) 0.96
Strain variation of lymphokine production and specific antibody secretion in mice infected with Mycobacterium lepraemurium. Cell Immunol (1985) 0.96
Epidemic Pseudomonas aeruginosa serotype O16 bacteremia in hematology-oncology patients. J Clin Microbiol (1989) 0.95
A one-year prospective study (1994-1995) for a first evaluation of tuberculosis transmission in French prisons. Int J Tuberc Lung Dis (2000) 0.94
[Delayed local reaction (DLR) after BCG vaccination in mice. II.--Correlations with the immune response (author's transl)]. Ann Immunol (Paris) (1978) 0.94
Relapses after stopping chemotherapy for experimental tuberculosis in genetically resistant and susceptible strains of mice. Clin Exp Immunol (1989) 0.93
Novel, plasmid-encoded, TEM-derived extended-spectrum beta-lactamase in Klebsiella pneumoniae conferring higher resistance to aztreonam than to extended-spectrum cephalosporins. Antimicrob Agents Chemother (1993) 0.92